在乳腺癌中增强免疫治疗的CRISPR/Cas9中介淘汰策略
1Department of Gynecology and Obstetrics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, 213000, China. LinLin41539@gmail.com.
Naunyn-Schmiedeberg's archives of pharmacology
|June 22, 2024
概括
结合CRISPR/Cas9基因淘汰和免疫疗法,提供了一种新的方法,通过向癌细胞和增强免疫反应来增强乳腺癌治疗. 这一策略有望彻底改变治疗方法,尽管安全性需要仔细评估.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 由于其遗传复杂性和死亡率,乳腺癌存在重大治疗挑战.
- 目前的免疫疗法看起来很有前途,但可能受到癌细胞逃避机制的限制.
研究的目的:
- 探索将CRISPR/Cas9基因淘汰与免疫治疗相结合的协同潜力,以加强乳腺癌治疗.
- 审查基因淘汰如何克服乳腺癌中的免疫逃避.
主要方法:
- 关于CRISPR/Cas9基因编辑在瘤学中的应用现有文献的综述.
- 对乳腺癌免疫治疗策略的分析.
- 探索基因淘汰目标,以增强免疫系统对癌细胞的识别.
主要成果:
- 克里斯普尔/卡斯9基因淘汰提供精确的基因改变以向癌细胞.
- 结合CRISPR/Cas9和免疫疗法可以通过禁用免疫逃避途径来增加治疗效果.
- 通过向基因编辑来最大限度地减少非目标效应的潜力.
结论:
- 克里斯普尔/卡斯9介导基因淘汰和免疫治疗的结合是促进乳腺癌治疗的有希望的策略.
- 需要进一步的研究来优化这些综合方法,并解决安全考虑,如非目标效应和免疫反应.
相关概念视频
CRISPR
50.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Homologous Recombination
50.4K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.4K
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K


